Zymeworks (ZYME) Depreciation & Amortization (CF) (2022 - 2026)

Zymeworks (ZYME) reported Depreciation & Amortization (CF) of $963000.0 for Q1 2026, down 1.83% on a YoY basis from $981000.0 in Q1 2025, and up 7.24% sequentially from $898000.0 in Q4 2025.

Zymeworks (ZYME) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends

Zymeworks (ZYME) has 5 years of Depreciation & Amortization (CF) data on file, last reported at $963000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 1.83% year-over-year to $963000.0; the trailing twelve-month figure through Mar 2026 stood at $3.7 million (down 11.12% YoY), and the FY2025 full-year result was $3.7 million, down 12.39% from the prior year.
  • Depreciation & Amortization (CF) advanced to $963000.0 in Q1 2026, from $898000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.4 million in Q3 2023 to a low of $885000.0 in Q2 2025.
  • A 5-year average of $1.3 million and a median of $1.1 million in 2024 frame the typical range for Depreciation & Amortization (CF).
  • Across the five-year window, Depreciation & Amortization (CF) soared 73.36% in 2023 and tumbled 56.89% in 2024, its largest moves.
  • Tracing ZYME's Depreciation & Amortization (CF) over 5 years: stood at $1.2 million in 2022, then jumped by 33.33% to $1.5 million in 2023, then slumped by 35.09% to $997000.0 in 2024, then slipped by 9.93% to $898000.0 in 2025, then grew by 7.24% to $963000.0 in 2026.
  • Business Quant data shows ZYME's Depreciation & Amortization (CF) at $963000.0 in Q1 2026, $898000.0 in Q4 2025, and $905000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 196,658.72
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 41.14 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 2.20 Mn
10 Zymeworks 1.73 Bn 1.36 Bn - 963,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 963,000.00
Mar 31, 2026 963,000.00
Dec 31, 2025 898,000.00
Dec 31, 2025 898,000.00
Sep 30, 2025 905,000.00
Sep 30, 2025 905,000.00
Jun 30, 2025 885,000.00
Jun 30, 2025 885,000.00
Mar 31, 2025 981,000.00
Mar 31, 2025 981,000.00
Dec 31, 2024 997,000.00
Dec 31, 2024 997,000.00
Sep 30, 2024 1.04 Mn
Sep 30, 2024 1.04 Mn
Jun 30, 2024 1.10 Mn
Jun 30, 2024 1.10 Mn
Mar 31, 2024 1.06 Mn
Mar 31, 2024 1.06 Mn
Dec 31, 2023 1.54 Mn
Dec 31, 2023 1.54 Mn